Terms: = Lung cancer AND DNMT3A, Q9Y6K1, 1788, ENSG00000119772, DNMT3A2, M_HsaIIIA AND Prognosis
18 results:
1. Comparative genomics between matched solid and lepidic portions of semi-solid lung adenocarcinomas.
Woodard GA; Ding V; Cho C; Brand NR; Kratz JR; Jones KD; Jablons DM
Lung Cancer; 2023 Jun; 180():107211. PubMed ID: 37121213
[TBL] [Abstract] [Full Text] [Related]
2. MGL S3 Chimeric Enzyme Drives Apoptotic Death of EGFR-Dependent cancer Cells through ERK Downregulation.
Bondarev N; Ivanenko K; Khabusheva E; Lebedev T; Manukhov I; Prassolov V
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361596
[TBL] [Abstract] [Full Text] [Related]
3. Pulmonary epithelial-myoepithelial carcinoma (P-EMC) with focal high grade transformation: Molecular and cytologic findings.
Charles R; Murray S; Gray E; Hu J
Diagn Cytopathol; 2022 Jun; 50(6):E156-E162. PubMed ID: 35100487
[TBL] [Abstract] [Full Text] [Related]
4. Comparative analysis of the long-term outcomes of segmentectomy and lobectomy for stage IA1 lung adenocarcinoma in patients with or without previous malignancy of other organs: a population-based study.
Bai W; Zhang J; Wang Y; Zhou M; Liu L; Wang G; Zhao K; Gao X; Li S
Expert Rev Anticancer Ther; 2022 Feb; 22(2):215-228. PubMed ID: 34596477
[TBL] [Abstract] [Full Text] [Related]
5. Surgical prognosis of Synchronous Multiple Primary lung cancer: Systematic Review and Meta-Analysis.
Nie Y; Wang X; Yang F; Zhou Z; Wang J; Chen K
Clin Lung Cancer; 2021 Jul; 22(4):341-350.e3. PubMed ID: 33243621
[TBL] [Abstract] [Full Text] [Related]
6. Male-Specific Long Noncoding RNA
Lai IL; Chang YS; Chan WL; Lee YT; Yen JC; Yang CA; Hung SY; Chang JG
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31311130
[TBL] [Abstract] [Full Text] [Related]
7. ROR1-targeted delivery of miR-29b induces cell cycle arrest and therapeutic benefit in vivo in a CLL mouse model.
Chiang CL; Goswami S; Frissora FW; Xie Z; Yan PS; Bundschuh R; Walker LA; Huang X; Mani R; Mo XM; Baskar S; Rader C; Phelps MA; Marcucci G; Byrd JC; Lee LJ; Muthusamy N
Blood; 2019 Aug; 134(5):432-444. PubMed ID: 31151986
[TBL] [Abstract] [Full Text] [Related]
8. dnmt3a/3B overexpression might be correlated with poor patient survival, hypermethylation and low expression of ESR1/PGR in endometrioid carcinoma: an analysis of The cancer Genome Atlas.
He D; Wang X; Zhang Y; Zhao J; Han R; Dong Y
Chin Med J (Engl); 2019 Jan; 132(2):161-170. PubMed ID: 30614867
[TBL] [Abstract] [Full Text] [Related]
9. DNA methyltransferase 3A isoform b contributes to repressing E-cadherin through cooperation of DNA methylation and H3K27/H3K9 methylation in EMT-related metastasis of gastric cancer.
Cui H; Hu Y; Guo D; Zhang A; Gu Y; Zhang S; Zhao C; Gong P; Shen X; Li Y; Wu H; Wang L; Zhao Z; Fan H
Oncogene; 2018 Aug; 37(32):4358-4371. PubMed ID: 29717263
[TBL] [Abstract] [Full Text] [Related]
10. Sulforaphane epigenetically demethylates the CpG sites of the miR-9-3 promoter and reactivates miR-9-3 expression in human lung cancer A549 cells.
Gao L; Cheng D; Yang J; Wu R; Li W; Kong AN
J Nutr Biochem; 2018 Jun; 56():109-115. PubMed ID: 29525530
[TBL] [Abstract] [Full Text] [Related]
11. Downregulation of dnmt3a by miR-708-5p Inhibits lung cancer Stem Cell-like Phenotypes through Repressing Wnt/β-catenin Signaling.
Liu T; Wu X; Chen T; Luo Z; Hu X
Clin Cancer Res; 2018 Apr; 24(7):1748-1760. PubMed ID: 28972040
[No Abstract] [Full Text] [Related]
12. MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway.
Wei CH; Wu G; Cai Q; Gao XC; Tong F; Zhou R; Zhang RG; Dong JH; Hu Y; Dong XR
J Hematol Oncol; 2017 Jun; 10(1):125. PubMed ID: 28629431
[TBL] [Abstract] [Full Text] [Related]
13. dnmt3a expression pattern and its prognostic value in lung adenocarcinoma.
Husni RE; Shiba-Ishii A; Iiyama S; Shiozawa T; Kim Y; Nakagawa T; Sato T; Kano J; Minami Y; Noguchi M
Lung Cancer; 2016 Jul; 97():59-65. PubMed ID: 27237029
[TBL] [Abstract] [Full Text] [Related]
14. Increased NQO1 but not c-MET and survivin expression in non-small cell lung carcinoma with KRAS mutations.
Yilmaz A; Mohamed N; Patterson KA; Tang Y; Shilo K; Villalona-Calero MA; Davis ME; Zhou X; Frankel W; Otterson GA; Beall HD; Zhao W
Int J Environ Res Public Health; 2014 Sep; 11(9):9491-502. PubMed ID: 25222473
[TBL] [Abstract] [Full Text] [Related]
15. [Mediastinal masses: case series].
Monteiro R; Alfaro TM; Correia L; Simão A; Robalo Cordeiro C; Carvalho A; Costa JM
Acta Med Port; 2011; 24(6):899-904. PubMed ID: 22713183
[TBL] [Abstract] [Full Text] [Related]
16. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B.
Fabbri M; Garzon R; Cimmino A; Liu Z; Zanesi N; Callegari E; Liu S; Alder H; Costinean S; Fernandez-Cymering C; Volinia S; Guler G; Morrison CD; Chan KK; Marcucci G; Calin GA; Huebner K; Croce CM
Proc Natl Acad Sci U S A; 2007 Oct; 104(40):15805-10. PubMed ID: 17890317
[TBL] [Abstract] [Full Text] [Related]
17. Alteration of DNA methyltransferases contributes to 5'CpG methylation and poor prognosis in lung cancer.
Lin RK; Hsu HS; Chang JW; Chen CY; Chen JT; Wang YC
Lung Cancer; 2007 Feb; 55(2):205-13. PubMed ID: 17140695
[TBL] [Abstract] [Full Text] [Related]
18. DNA methyltransferases messenger RNA expression and aberrant methylation of CpG islands in non-small-cell lung cancer: association and prognostic value.
Vallböhmer D; Brabender J; Yang D; Schneider PM; Metzger R; Danenberg KD; Hölscher AH; Danenberg PV
Clin Lung Cancer; 2006 Jul; 8(1):39-44. PubMed ID: 16870044
[TBL] [Abstract] [Full Text] [Related]
